Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Eigenthaler, Martin ^a   Engelhardt, Stefan ^a   Schinke, Birgitta ^a   Kobsar, Anna ^a   Schmitteckert, Eva ^a   Gambaryan, Stepan ^a   Engelhardt, Catherine M ^a   Krenn, Veit ^b   Eliava, Marina ^a   Jarchau, Thomas ^a   Lohse, Martin J ^a   Walter, Ulrich ^a   Hein, Lutz ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Inst fur Pharmakol und Toxikol   (Germany)

Author keywords

Arrhythmia; Hypertrophy; Transgenic mice

Indexed keywords

MAMMALIAN ENABLED PROTEIN; MYOSIN HEAVY CHAIN; PROTEIN; PROTEIN ENABLED VASODILATOR STIMULATED PHOSPHOPROTEIN; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN; VINCULIN; ZYXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HEART DILATATION; HEART MUSCLE; HYPERTROPHY; INTERCALATED DISK; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TRANSGENE; TRANSGENIC MOUSE;

EID: 0344009607     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00362.2003     Document Type: Article

References (33)

1. Ahern-Djamali SM, Comer AR, Bachmann C, Kastenmeier AS, Reddy SK, Beckerle MC, Walter U, and Hoffmann FM. Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains. Mol Biol Cell 9: 2157-2171, 1998.
2. Aszodi A, Pfeifer A, Ahmad M, Glauner M, Zhou XH, Ny L, Andersson KE, Kehrel B, Offermanns S, and Fässler R. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 18: 37-48, 1999.
3. Ball LJ, Kuhne R, Hoffmann B, Hafner A, Schmieder P, Volkmer-Engert R, Hof M, Wahl M, Schneider-Mergener J, Walter U, Oschkinat H, and Jarchau T. Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity. EMBO J 19: 4903-4914, 2000.
4. Bear JE, Loureiro JJ, Libova I, Fässler R, Wehland J, and Gertler FB. Negative regulation of fibroblast motility by Ena/VASP proteins. Cell 101: 717-728, 2000.
5. Belkin AM, Ornatsky OI, Glukhova MA, and Koteliansky VE. Immunolocalization of meta-vinculin in human smooth and cardiac muscles. J Cell Biol 107: 545-553, 19886.
6. Engelhardt S, Hein L, Wiesmann F, and Lohse MJ. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96: 7059-7064, 1999.
7. Gertler FB, Niebuhr K, Reinhard M, Wehland J, and Soriano P. Mena, a relative of VASP and Drosophila enabled, is implicated in the control of microfilament dynamics. Cell 87: 227-239, 1996.
8. Haffner C, Jarchau T, Reinhard M, Hoppe J, Lohmann SM, and Walter U. Molecular cloning, structural analysis, and functional expression of the proline-rich focal adhesion and microfilament-associated protein VASP. EMBO J 14: 19-27, 1995.
9. Halbrügge M and Walter U. Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem 185: 41-50, 1989.
10. Hauser W, Knobeloch KP, Eigenthaler M, Gambaryan S, Krenn V, Geiger J, Glazova M, Rohde E, Horak I, Walter U, and Zimmer M. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc Natl Acad Sci USA 96: 8120-8125, 1999.
11. 2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402: 181-184, 1999.
12. Hein L, Stevens ME, Barsh GS, Pratt RE, Kobilka BK, and Dzau VJ. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci USA 94: 6391-6396, 1997.
13. Hein S, Kostin S, Heling A, Maeno Y, and Schaper J. The role of the cytoskeleton in heart failure. Cardiovasc Res 45: 273-278, 2000.
14. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klövekorn WP, Schlepper M, Schaper W, and Schaper J. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86: 846-853, 2000.
15. Huttelmaier S, Mayboroda O, Harbeek B, Jarchau T, Jockusch BM, and Rudiger M. The interaction of the cell-contact proteins VASP and vinculin is regulated by phosphatidylinositol-4,5-bisphosphate. Curr Biol 8: 479-488, 1998.
16. Kostin S, Scholz D, Shimada T, Maeno Y, Mollnau H, Hein S, and Schaper J. The internal and external protein scaffold of the T-tubular system in cardiomyocytes. Cell Tissue Res 294: 449-460, 1998.
17. Laine RO, Zeile W, Kang F, Purich DL, and Southwick FS. Vinculin proteolysis unmasks an ActA homolog for actin-based Shigella motility. J Cell Biol 138: 1255-1264, 1997.
18. Lanier LM, Gates MA, Witke W, Menzies AS, Wehman AM, Macklis JD, Kwiatkowski D, Soriano P, and Gertler FB. Mena is required for neurulation and commissure formation. Neuron 22: 313-325, 1999.
19. Liu K, Li L, Nisson PE, Gruber C, Jessee J, and Cohen SN. Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol Cell Biol 19: 3696-3703, 1999.
20. Maeda M, Holder E, Lowes B, Valent S, and Bies RD. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95: 17-20, 1997.
21. Markert T, Krenn V, Leebmann J, and Walter U. High expression of the focal adhesion- and microfilament-associated protein VASP in vascular smooth muscle and endothelial cells of the intact human vessel wall. Basic Res Cardiol 91: 337-343, 1996.
22. Ng WA, Grupp IL, Subramaniam A, and Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res 69: 1742-1750, 1991.
23. Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Common J, Purkis PE, Whittock N, Leigh IM, Stevens HP, and Kelsell DP. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 9: 2761-2766, 2000.
24. Olson TM, Illenberger S, Kishimoto NY, Huttelmaier S, Keating MT, and Jockusch BM. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 105: 431-437, 2002.
25. Reinhard M, Jarchau T, and Walter U. Actin-based motility: stop and go with Ena/VASP proteins. Trends Biochem Sci 26: 243-249, 2001.
26. Renfranz PJ and Beckerle MC. Doing (F/L)PPPs: EVH1 domains and their proline-rich partners in cell polarity and migration. Curr Opin Cell Biol 14: 88-103, 2002.
27. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, and Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83: 504-514, 1991.
28. Seidman JG and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104: 557-567, 2001.
29. Smolenski A, Burkhardt AM, Eigenthaler M, Butt E, Gambaryan S, Lohmann SM, and Walter U. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn Schmiedebergs Arch Pharmacol 358: 134-139, 1998.
30. Towbin JA. The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 10: 131-139, 1998.
31. Vasioukhin V, Bauer C, Yin M, and Fuchs E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 100: 209-219, 2000.
32. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, and Yoshimura A. Spred is a Sprouty-related suppressor of Ras signalling. Nature 9: 647-651, 2001.
33. Xu W, Baribault H, and Adamson ED. Vinculin knockout results in heart and brain defects during embryonic development. Development 125: 327-337, 1998.